BofA Securities made an adjustment to the price target for Altria stock, bringing it down to $61 from the previous $65, while still maintaining a Buy rating on the shares. This change was announced by ...

Apple stock rises after the tech giant posts better-than-expected earnings and guides for solid growth, while Intel’s ...

Startup founders are inherently problem solvers. Whether it’s identifying a pain point inside an esoteric industry or building a better mousetrap, almost every journey centers on finding a way to make ...

The ASX 200 benchmark touched an all-time record of 8566 points before pulling back slightly. At around lunch time Friday, ...

S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication. 1,2 Furthermore, this drug has received ...

Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium ...

Neuronoff, Inc., a pioneer in minimally invasive neuromodulation solutions, today announced two major funding milestones totaling $5 million to advance its innovative Injectrode® technology. The ...

One of the NPP’s slogans was “Catching Thieves”, a sentiment the people eagerly supported. However, simply putting a “thief ...

Wall Street is coming off a losing session after the Federal Reserve paused its interest rate-cutting campaign, leaving its ...

A meeting was held at the Ministry of Health, on 28th January 2025, presided by Minister of Health, Dr. Nalinda Jayatissa at ...